Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
ponatinib use in chronic phase CML
.
Show all posts
Showing posts with label
ponatinib use in chronic phase CML
.
Show all posts
Wednesday, September 30, 2015
Vascular side effects prevent first-line ponatinib use in chronic phase CML
›
In continuation of my update on Ponatinib Ponatinib is highly active when given to patients within 6 months of developing c...
›
Home
View web version
